Investment
Features
FeesSafety
Academy
More
Pluang+

Peruvian Metals completes maintenance, reports steady production and gold-silver tailings potential at Aguila Norte plant

Market News
08 Sep 2026
Newsfile Corp
View Source
Bullish
Peruvian Metals completes maintenance, reports steady production and gold-silver tailings potential at Aguila Norte plant

Peruvian Metals Corp. completed maintenance on its Aguila Norte processing plant in Peru, maintaining full production capacity for 28 of the last 29 months. The plant processed 6,046 metric tonnes in July and August 2026. Recent sampling shows significant gold and silver remain in tailings, with high recovery rates confirmed, suggesting potential for additional revenue through tailings reprocessing. The company plans to seek permit modifications and continue underground sampling at other sites, aiming to sustain and expand production.

More News

Opus Genetics gets Buy rating ahead of key gene therapy data release on Sept 9, 2026.

Opus Genetics gets Buy rating ahead of key gene therapy data release on Sept 9, 2026.

Opus Genetics, a clinical-stage biotech focused on inherited retinal diseases, received a Buy rating and $8 price target from analyst Matthew Caufield in August 2026. The company plans to release topline Phase 1/2 data for its gene therapy OPGx-BEST1...

Analyst Insights
Bullish
1 hour ago
GE to acquire CPP for $11.75B, boosting aerospace casting capacity and earnings potential

GE to acquire CPP for $11.75B, boosting aerospace casting capacity and earnings potential

General Electric (GE) announced it will acquire Consolidated Precision Products (CPP) for $11.75 billion to enhance its aerospace casting production. This strategic move aims to strengthen GE's manufacturing capabilities and accelerate engine technol...

Analyst Insights
Bullish
1 hour ago
UNFI beats Q4 EPS estimates but misses revenue, expects growth ahead.

UNFI beats Q4 EPS estimates but misses revenue, expects growth ahead.

United Natural Foods, Inc. (UNFI) reported a Q4 adjusted EPS of $0.69, surpassing analyst expectations of $0.61, signaling strong profitability. However, revenue slightly missed estimates at $7.64 billion, down 0.7% from the previous year. Despite th...

Company Fundamentals
Bullish
1 hour ago
Ionis Pharmaceuticals gets $85 price target despite heart drug trial failure

Ionis Pharmaceuticals gets $85 price target despite heart drug trial failure

Ionis Pharmaceuticals faced a setback when its experimental heart drug pelacarsen failed a Phase 3 trial to reduce cardiovascular events, causing an 8.6% stock drop. However, an analyst from Canaccord Genuity maintained a bullish $85 price target, im...

Analyst Insights
Bullish
2 hours ago
Casey's General Stores to report Q3 earnings with strong analyst expectations on Sept 8, 2026.

Casey's General Stores to report Q3 earnings with strong analyst expectations on Sept 8, 2026.

Casey's General Stores will release its Q3 2026 earnings on September 8 after market close, with analysts expecting an EPS of $6.78 and revenue of $5.56 billion. The company has a strong history of exceeding earnings estimates, with an average surpri...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App